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Abstract 
 
Background 
Disease progression in multiple sclerosis (MS) is highly variable and predicting prognosis is 
notoriously challenging. Patients’ prognosis beliefs, responses to prognostic uncertainty and 
experiences of prognosis-related communication with healthcare professionals (HCPs) have 
received little study. These issues have implications for patients’ psychological adjustment and 
are important in the context of the recent development of personalised prognosis forecasting tools. 
This study explored patient perspectives on the experience of prognostic uncertainty, the 
formation of expectations about personal prognosis and the nature of received and desired 
prognosis communication.  
 
Methods 
15 MS patients participated in in-depth semi-structured interviews which were analysed using 
inductive thematic analysis.    
 
Results 
Six themes captured key aspects of the data: Experiencing unsatisfactory communication with 
HCPs, Appreciating and accepting prognostic uncertainty, Trying to stay present-focused, 
Forming and editing personal prognosis beliefs, Ambivalence towards forecasting the future, and 
Prognosis information delivery. MS patients report having minimal communication with HCPs 
about prognosis. Over time MS patients appear to develop expectations about their disease 
trajectories, but do so with minimal HCP input. Provision of prognosis information by HCPs 
seems to run counter to patients’ attempts to remain present-focused. Patients are often 
ambivalent about prognosis forecasting and consider it emotionally dangerous and of 
circumscribed usefulness. 
 
Conclusions 
HCPs must carefully consider whether, when and how to share prognosis information with 
patients; specific training may be beneficial. Future research should confirm findings about 
limited HCP-patient communication, distinguish predictors of patients’ attitudes towards 
prognostication and identify circumstances under which prognostic forecasting benefits patients.  
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Introduction    
 
Multiple sclerosis (MS) is a chronic, degenerative disease of the central nervous system. It  is the 
leading cause of non-traumatic neurological disability in young adults (1), and can produce an 
assortment of symptoms including visual disturbance, spasticity, speech distortions, bladder and 
bowel dysfunction, fatigue, pain and cognitive impairment. MS is also renowned for having a 
variable and uncertain trajectory. The vast majority of people with MS (pwMS) initially 
experience a relapsing-remitting phase; with around 80% of these converting, eventually, to a 
progressive phase where disability accumulates (2). Despite the identification of prognostic 
principles (3) accurate prediction of an individual patient’s short and long-term disease activity, 
progression and ultimate disability level remains challenging.   
 
Clinical guidelines (e.g. from the National Institute of Clinical Excellence (4)) emphasise the 
importance of open and honest communication and information provision for pwMS but make no 
specific recommendations about how an individual’s likely prognosis and the inherent 
uncertainty surrounding disease outcomes is communicated.  There is also little research 
regarding this communication. Clinical experience suggests that communication practices are 
probably highly variable, with each treating physician making an experience-based clinical 
judgement about their individual patient’s disease trajectory and then determining whether, when 
and how to communicate expectations and predictions to the patient. Heesen et al.(5) found that 
amongst mild-moderately affected pwMS from a German neurology clinic, very few (6%) had 
ever received prognostic counselling, although interestingly only a minority (11%) wanted more 
prognosis information than they had received. More recently, German research with severely 
affected patients uncovered dissatisfaction; most respondents considered communication about 
disease progression to be important but felt that doctors inadequately addressed  it(6). More 
generally, the unmet information needs of pwMS, especially at the time of diagnosis, are well-
documented (7, 8). 
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It is not surprising that uncertainty, or a lack of clarity or predictability, is noted to be a common 
experience for patients and their families; the uncertain and ambiguous nature of the disease and 
the implications of this for patients and their families has received substantial research attention 
(9). Although the meaning of the term ‘uncertainty’ is not always clearly operationalised or 
explicitly defined in the MS literature,  influential theoretical work by Mishel (10) defines illness 
uncertainty as multifactorial and encompassing complexities, doubts, and unpredictability 
relating to symptoms, diagnosis, treatment, relationships, disease progression and future planning.  
Overall, research in MS suggests that experiencing illness uncertainty contributes to emotional 
distress and the practical challenges associated with living with the disease.  A review established 
that patients who feel uncertain or lack a coherent understanding of their MS tend to score higher 
on psychological distress measures than those who consider themselves to have a clear 
understanding of their disease(11). Indeed patients’ understanding and perceptions of their 
condition are prominent factors within several key psychological models of adjustment to chronic 
illnesses (e.g. (11, 12)) with highly negative, fearful or incoherent illness perceptions viewed as 
contributing to distress and maladjustment. Furthermore, qualitative research highlights day-to-
day and longer-term uncertainty as being central to the experience of living with MS and 
problematic to come to terms with (13, 14). Importantly,  however, existing work on uncertainty 
in MS has not focused in on any specific source of uncertainty and has typically employed 
questionnaire measures of uncertainty that have been developed in line with Mischel’s 
multifactorial conceptualisation. Research specifically addressing the experience and impact of 
prognostic uncertainty in pwMS is lacking. 
 
 
Aims and research questions 
The current study explores how pwMS experience prognostic uncertainty and communication 
with HCPs about prognosis.  It aims to understand how prognostic uncertainty affects pwMS, if 
and how they form expectations about their disease trajectory and what communication they 
receive and want.  These topics are both interesting in their own right and timely to investigate 
given recent developments of an online analytical processing tool (OLAP) which supports 
individualised prognostic risk forecasting in MS (5, 15, 16).  The latest version of the tool 
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supports 30 year forecasting by predicting time to milestones including conversion to secondary 
progressive disease, EDSS 6 (i.e. walking using a stick), EDSS 8 (i.e. perambulated in wheelchair) 
and EDSS 10 (i.e. death from MS)(16).  Current work with this tool focusses on its use to support 
shared treatment decision-making.  However, the availability of personalised prognostic 
information has repercussions beyond the realm of treatment decision-making and could 
influence the psychosocial adjustment of pwMS and their families.  Initial research using an 
earlier (3 year forecast) version of the OLAP tool suggested that prognosis forecasting was 
understandable and acceptable to patients(5). However, it remains unclear what psychological 
benefits (e.g. reduced emotional distress following a reassuring prognosis estimate) or harms 
(increased distress and hopelessness following a more pessimistic prognosis estimate) the tool 
could elicit, whether pwMS would welcome its use, and under what circumstances it would prove 
relevant and useful.  For these reasons we embarked on an investigation of pwMS’s views and 
experiences of prognostic uncertainty and prognosis communication. The aim was to provide 
insight into the context in which prognosis prediction and communication aids such as the OLAP 
tool would operating in, and the range of possible consequences of encouraging HCPs to consider 
and discuss prognosis more frequently, extensively and openly.  
 
 
 
Method 
 
Data collection 
This study was approved by the University of Southampton ethics committee. Data was collected 
between Spring 2014 and Summer 2015 via semi-structured telephone interviews with pwMS.  
Telephone interviews were chosen to allow participants from a wide geographical area (across 
the UK) to participate, to limit burden on pwMS and to ensure that mobility limitations, MS 
symptoms, work or family commitments did not preclude participation.  Although some 
researchers consider face-to-face interviews superior for establishing a rapport with participants 
when researching emotive topics, we have previously successfully used telephone interviews to 
elicit deeply personal, rich and detailed accounts of illness experiences in pwMS  (17, 
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18).Choosing telephone interviews over face-to-face interviews allowed us to connect with 
pwMS who would have found a face-to-face meeting either impracticable or intimidating. 
 
Five of the interviews were conducted by LD (an academic health psychologist with substantial 
experience in qualitative research) and 10 were conducted by EM (a medical student). EM had 
practical training in qualitative interviewing and ongoing supervision from LD throughout data 
collection.  A schedule of open-ended questions (Supplementary Information) encouraged 
participants to discuss their understanding of how MS might affect them over the longer-term, 
how they had reached their current understanding, how any uncertainty about prognosis affected 
their life, whether and under what circumstances they would want more information about their 
likely prognosis, and anticipated consequences of receiving this information. Participants were 
encouraged to discuss issues they considered to be personally important and prompts were used 
to further probe topics they spontaneously raised. The interview schedule was developed by LD 
and EM with input from IG. Following its first use minor edits to wording and question order 
were made to improve its comprehensibility and relevance.   A series of brief questions were used 
to ascertain demographic and clinical characteristics. Interviews lasted between 20 and 78 
minutes (mean 46.5) and were audio-recorded and transcribed verbatim. 
 
Participants 
Inclusion criteria were a diagnosis of MS and age ≥18 years. An overview of the study was 
disseminated via the UK MS Society website and social media and through emails to members of 
the UK MS Register. PwMS who were interested in participating responded to the researchers 
directly. Participants received information sheets and signed consent forms prior to enrolment.  
23 people expressed interest in the study.  We begun by interviewing all participants that 
consented but as data collection (and concurrent data analysis) progressed we deliberately 
sampled from the pool of available participants to ensure the final sample varied in terms of MS 
course (relapsing remitting, primary and secondary progressive), time since diagnosis, age and 
gender. Purposive sampling was possible because participants typically disclosed this information 
to the researcher at the point of expressing interest or of returning the consent form. At later 
stages of the data collection we also made deliberate efforts to attract interest from younger and 
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more newly diagnosed pwMS by editing the recruitment adverts/information to make it clear that 
we were especially interested in hearing from people with these characteristics. Once we began 
purposive sampling we thanked those that consented for their interest and willingness to be 
involved and advised them that we were nearing the end of the project and narrowing our focus in 
order to explore the experiences of participants with particular profiles. Where relevant we 
advised volunteers that their participation would not required and offered them the opportunity to 
receive a summary of the research results.  Recruitment ceased after 15 interviews as by this 
point we had succeeded in collecting data from a diverse sample and analysis had reached the 
point where no new themes were occurring (i.e. saturation).   Participants received a £15 retail 
voucher to thank them for their time. 
 
Table 1 shows participant characteristics. Fifteen participants were interviewed (twelve (80%) 
female). Age ranged from 31 to 68 (median 48 years).  Eight participants identified themselves as 
having relapsing-remitting MS, four secondary progressive and three primary progressive.  Time 
since diagnosis ranged from 2 months to 22 years (median 9 years).  The clinical and 
sociodemographic characteristics of the 15 participants broadly map onto the characteristics of 
UK MS patients including the high (2.4 to 1(19)) female to male gender ratio. 
 
Table 1: Participant Characteristics 
 
 Median (range) or N (%) 
Gender 
Female 
Male 
 
12 (80%) 
3 (20%) 
Age 48.0 (31-68 years) 
Marital status 
Single 
Co-habiting 
Married 
Divorced 
 
6 (40%) 
2 (13.3%) 
6 (40%) 
1 (6.7%) 
Type of MS1 
RR 
SP 
PP 
 
8 (53.3%) 
4 (26.7%) 
3 (20%) 
Time since Diagnosis (years) 1 9.0  (2 months- 22 years) 
1Self-reported by participants 
 
Analysis 
The data was analysed using thematic analysis (20), a systematic, robust method for developing 
rich, detailed accounts of qualitative data.  LD undertook the analysis; EM and KB gave input 
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into emerging themes and coding manuals. The analysis was inductive, meaning that it was built 
upwards from the data, rather than originating from a pre-existing theoretical framework or 
researcher expectations. Recordings and transcripts were listened to and read repeatedly in order 
to immerse the researcher in the data. NVivo software (v10) was used to support coding of the 
data. Initial coding was then undertaken whereby descriptive labels were attached to text 
segments which contained salient material relating to the research questions. Analysis proceeded 
to develop themes from these ‘codes’ by clustering together similar codes.  Analysis commenced 
after ten interviews had been completed. Further data collection then took place, purposively 
sampling younger and more recently diagnosed participants. This concurrent data 
collection/analysis strategy allowed us to elaborate on emerging themes and created a more 
rigorous analysis since we deliberately sought data that might not fit with our identified patterns 
and accounts. Themes were progressively reviewed, refined, organised and relabelled until a set 
of rich, coherent themes and subthemes describing key aspects of the data was produced.  
 
Results 
 
The analysis identified 6 key themes which incorporated 21 subthemes (see Table 2).   In the 
following sections, the themes are described and illustrated using quotations from participants 
(anonymised, and labelled according to age, gender, MS type and years since diagnosis). Except 
where specifically stated, the analysis did not reveal different patterns of findings that could be 
clearly related to participants clinical or sociodemographic characteristics.  
 
Table 2: Themes and Subthemes 
 
Theme Subtheme 
Experiencing unsatisfactory 
HCP communication  
• The legacy of difficult diagnosis experiences 
• Limited and/or unexploited opportunities for discussing 
prognosis/progression  
• Perceived differences between neurologists and nurses 
Appreciating and accepting 
prognostic uncertainty 
• Understanding the variability of progression and 
prognosis in MS 
• Philosophical/spiritual acceptance of uncertainty 
Trying to stay present-
focussed 
• Not looking ahead as a coping strategy 
• Mind wandering into dangerous territory 
Forming and editing personal 
prognosis beliefs 
• Coming to one’s own conclusion about likely prognosis 
• Exposure to other pwMS  
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 • Minimal & vague HCP input 
• Finding things out for oneself 
• Growing experience with own disease 
Ambivalence towards 
forecasting the future 
• Indecision and contradiction 
• Assumption that forecast would be bad news 
• Danger of demoralisation and despair 
• Usefulness of information 
Prognosis information 
delivery 
• Timing and receptiveness 
• Personality differences 
• Authority and expertise 
• Setting  
• Ongoing support vs one-off discussion 
 
 
 
Experiencing unsatisfactory HCP communication  
 
Participants’ accounts of interactions with HCPs about their prognosis frequently digressed to 
detailed emotional accounts of negative communication and support experiences around the time 
of diagnosis.  
 
I was left over the weekend with no knowledge, no ability to contact anyone and spent most of the 
weekend on the phone to the Samaritans. (P12: Female, 44, RRMS, 1yr) 
 
His lack of communication was just really upsetting. (P13: Female, 42, RRMS, 2mths) 
 
Distress relating to diagnosis experiences clearly persisted over time and appeared to create 
negative expectations and perceptions of future interactions with doctors (particularly 
neurologists). Neurologists tended to be viewed as ‘diagnosers’ with little time and interest in 
patients’ ongoing struggles. In contrast, MS nurses tended to be perceived as ideally situated for 
discussing emotional and practical issues relating to MS. Participants tended to be positive about 
the communication and support they received from nurses although they did not all have access 
to a nurse and were conscious that the valued supportive role nurses could provide was limited by 
their workload.  
 
MS nurses are the ones who generally are the best ones to talk to you face-to-face. (P10: Female, 
51, RRMS, 10yrs) 
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All participants perceived that opportunities to discuss their prognosis had been limited. In some 
cases this appeared to reflect infrequency of contact with HCPs, the brief nature of consultations 
and abrupt clinician (especially Neurologist) communication style. In other cases, the participant 
deliberately held back questions because they did not feel ready to hear the answers. This sense 
of not being ready and wanting to ‘hold back’ appears to relate to the ‘Trying to stay present-
focused ‘ theme described in more detail below.  
 
I didn’t want to know about it that much anyway, because I was just trying to absorb it all. (P12: 
Female, 44, PPMS, 2yrs) 
 
Appreciating and accepting prognostic uncertainty 
 
Participants clearly comprehended MS to be a variable disease with inherent uncertainty.   
Participants were tolerant of the fact that HCPs did not have all the answers and could not 
confidently predict how MS would affect them over time 
 
I know due to the nature of MS … that they probably couldn’t answer all of the questions... a lot 
of the questions that I have had. (P13: Female, 42, RRMS, 2mths) 
 
Along with theoretical ‘knowing’ that MS prognosis is uncertain, several participants described 
philosophical stances towards accepting an inability to know or influence the future. This 
perspective was described as originating from religious belief or as an outcome of undertaking 
psychological therapy 
 
I recognise open answers are a reality in the whole of life. (P11: Female,48, RRMS, 1yr) 
 
Trying to stay present-focussed 
 
A ubiquitous strategy for living with an uncertain but threatening future was to stay in the present 
as much as possible.  “l I just try to live one day at a time”(P3: Female, 65,SPMS, 3yrs)”, “take 
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it as it comes” (P12: Female, 44, PP, 2yrs) and “get on with it [life]”  (P2, Male, 48, PPMS, 
20yrs & P11, Female, 48, RRMS, 1yr), “try not to think about it too much” (P10, Female, 51, 
RRMS, 14yrs).  This approach appeared to be based on the wisdom that “whatever will be will be” 
(P1, Female, 45, RRMS, 16yrs &P13, Female, 42, RRMS, 2mths) and that “if the worst does 
happen, I’ll deal with that as and when” (P13, Female, 42, RRMS, 2mths). This present-oriented 
approach appeared to inhabit a spectrum ranging from those who had extensively considered 
future scenarios then concluded that their time/energy is best spent dealing with day-to-day 
problems and pleasures, to those who (aware or not) avoided thinking about the future because 
they feel unable to face it .  
 
It’s not wanting to realise what the, it’s realising that things could get worse or that things, that 
things will get worse but it’s hiding away, it’s more comforting. (P2: Male, 48, PPMS, 20yrs) 
I refuse to think about what is going to happen, I don’t like that I’m afraid. (P8: Female, 53, SP, 
17yrs) 
Despite attempting to be present-focussed, participants inevitably experienced thoughts and 
worries about future disability and dependence.  For instance, one participant (P3: Female, 65, SP, 
9yrs) described a deliberate present-oriented approach to coping with MS but also revealed 
intrusive, distressing future-related thoughts about becoming dependent on others and spoke of 
how she had contemplated assisted suicide if such circumstances arose. 
 
Forming and editing personal beliefs about prognosis 
 
Despite discussing the inherent uncertainty surrounding MS progression and declaring that they 
did not know their likely prognosis, most participants nevertheless described well-formed 
personal beliefs about their prognosis. Early beliefs seemed to be strongly influenced by salient, 
emotional images or memories of other pwMS they knew personally, or had seen in the media. 
Often these individuals had severe, debilitating disability due to MS and accordingly early 
personal prognosis beliefs tended to be fearful and extreme. 
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And other people I know have got it are, absolutely, are stricken with it, I’ve got one on the verge 
of death. (P11: Female, 48, RRMS, 1yr) 
 
[I have] little experience of good stories, mainly bad, and all with the outcome of eventually 
death, which doesn’t really, reinforce your own situation very well. (P6: Male, 62, PPMS, 21 
years) 
Early beliefs appeared to evolve over time and be subject to ongoing editing and revision as other 
sources of information about MS prognosis were encountered. Participants typically describe 
HCPs as only a minor influence in how their prognosis understanding came about.  Importantly 
though, HCPs communication appeared to attenuate or moderate early fearful beliefs about 
prognosis by providing verbal explanations about the variability of outcomes and the non-
necessity of progression and/or severe decline.   
 
I immediately thought it was a degenerative disease because I didn’t know anything about it. 
Umm… and he [the neurologist] said ‘not so, necessarily’. (P12: Female, 44, PPMS, 2yrs) 
 
Some participants described how their neurologists had given indications that their MS was either 
progressing slowly or not highly active.  This communication – tentatively positive yet vague- 
was frequently the only conversations about prognosis participants remembered having with 
HCPs. Others claimed to have never received information about their likely prognosis from HCPs. 
 
But the prognosis I think was quite vague. (P13: Female, 42, RRMS, 2mths) 
I don’t think I was told anything about how it would progress. (P2: Male, 48, PP, 20yrs] 
In the absence of clear, timely and detailed information about likely prognosis from HCPs most 
participants described that in the months or years after diagnosis they undertook extensive 
personal research, using various sources including the internet, journals and MS organisations. 
They recognised the variable quality of information and were sometimes frustrated by the lack of 
personally tailored information. They also often described consciously avoiding very negative 
information and seeking out positivity.  
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Another influence on the development of prognosis beliefs was the individual’s growing 
experience with their own disease.  
 
I know it’s very slow for me. (P11: Female, 48, RRMS, 1yr) 
 
Participants who had several years or decades of MS experience appeared to base their 
understandings of future likelihoods on their experiences to date (including looking back with 
hindsight at pre-diagnosis disease activity). This meant that pwMS who were many years post-
diagnosis or post symptom onset expressed more confidence about how they expected their 
disease to affect them than those more recently diagnosed. People tended to believe that future 
experiences would mirror past experiences.    
 
Going on past time, past diagnosis, the amount of time that I’ve had the MS then it’s more likely 
now to stay on the same level now for an indefinite period, there shouldn’t be any rapid decline 
or rapid improvement. (P2: Male, 48, PPMS, 20yrs) 
I’ve got experience of it in the last 5 years. It’s accelerating. (P6: Male, 62, PPMS, 21 yrs) 
I can clearly see there is a long slow deterioration. But it’s twenty years I am looking at. (P11:, 
Female,48, RRMS, 1yr) 
 
Ambivalence towards forecasting the future 
 
Participants were often unable to settle on a position about whether they wanted more insight into 
their likely long-term prognosis. Participants changed their minds backwards and forwards during 
the interview and demonstrated internal conflict. 
 
I kind of presumed that it wasn’t actually possible to … to tell. But God if it was possible I would 
really like to know. I think… Oh God, or do I? Actually yes I would, of course I would. (P13: 
Female, 42, RRMS, 2mths) 
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Oh I don’t know. Maybe, I don’t know, Yeah I think so, I’d like to know.  (P2: Male, 48, PPMS, 
20 yrs) 
Would that be useful? You know this? That’s a real toughy, I’ve never even thought of that before. 
Would I want to know? Um, yeah I think I would, I think I would but I’m not 100%. It’s a toughy 
though isn’t it? (P1: Female, 45, RRMS, 16yrs) 
Because participants were not pressed to arrive at a final, unambiguous answer during the 
interviews, reporting frequencies “for” and “against” more prognosis information is not 
straightforward. However, considering overall interview content, five participants were broadly 
classifiable as wanting more information, six as not wanting more information, and four as very 
unsure. No relationships between information preferences and disease type (progressive vs. 
relapsing-remitting), disease duration, gender or age were apparent. 
 
The hypothetical nature of accurately predicting MS progression appeared to compound the 
participants’ difficulties in articulating their views, as did the challenge that they would only be 
able to judge the likely impact once they had heard whether their prognosis was positive or 
negative.  
 
Often, participants appeared to assume that information about the future would be bad news. A 
dominant concern was that negative information would elicit hopelessness and demoralisation. 
 
If the future is really bad and really bleak then if I knew about that now then I suppose I could be 
tempted to, to just, give up now or something. (P2: Male, 48, PPMS, 20yrs) 
If I had to think about what could happen, well then, you know, you might as well shoot me. (P10: 
Female, 51, RRMS, 14yrs) 
Would I want to know? No I wouldn’t. Because I think it can make you cuckcoo, (P9: Female, 38, 
RRMS, 8yrs) 
I think ignorance is bliss in some ways. (P13: Female, 42, RRMS, 2mths) 
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Those that had already experienced moderate to severe disability believed that mental adaptation 
to a slow, creeping progression seemed easier to handle than knowing what one must face in 
advance.  
 
I find that the changes are so gradual and over time that you kind of, each little thing that 
happens you get used to it, before something else will happen. It’s not happening all at once, 
each change is gradual and easier to deal with that way. (P8: Female, 53, SPMS, 17yrs) 
Perceived usefulness of prognosis information appeared pivotal in whether participants would 
want to receive it.  Often the information was not considered useful as participants did not 
believed it would change anything for them. 
 
If somebody knew something was going to happen but they knew how to treat it, then I would 
want to know, then you’d want the treatment. But if there is no treatment and there is nothing you 
can do about it then you probably wouldn’t want to know. (P10: Female, 51, RRMS, 14yrs) 
No, it’s almost better to just avoid it. I don’t think it makes any difference about knowing. (P11: 
Female, 48, RRMS, 1yr) 
 
What would you do with that information then?  And you can’t change it. Why bother knowing it 
anyway? (P2: Male, 48, PPMS, 20yrs) 
If they could tell me then it wouldn’t make any difference. (P5: Female, 68, SPMS, 13yrs) 
Several participants did believe that receiving prognosis information would be useful. 
Anticipated impacts included prompting them to undertake personally valued activities whilst 
physically able, taking life easier to try to influence disease outcomes, financial and practical 
planning and preparing family members. 
 
I would be looking to see if there were any answers, solutions to the problem and if you don’t 
know then you can’t look for solutions can you. (P10: Female, 51, RRMS, 14yrs) 
I might think of moving to a bungalow or something like that. (P10: Female, 51, RRMS, 14yrs) 
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I would like to know what I am dealing with…. But I would just want to prepare, I suppose the 
best I can, prepare my children. (P13: Female, 42, RRMS, 2mths) 
 
If I was told I would be in a wheelchair in ten years’ time, there is loads of things I would want to 
do, before that. (P13: Female, 42, RRMS, 2mths) 
 
 
Views about delivering prognosis information 
 
Participants’ believed that HCPs must make challenging judgements about what prognosis 
information to share and when. Participants suggested that individual and personality differences 
influenced information preferences.  
 
Some people can understand and take in information a bit more than other people can so they 
need to be careful about how they tell people. (P2: Male, 48, PPMS, 20yrs) 
I think it is just judging the patient. (P12: Female, 44, PPMS, 2yrs) 
I think, it’s very hard to know whether someone wants to know, or not,… unless you actually ask 
the question but then if you say ‘would you like to know?’, I don’t know, it depends on the 
individual, on the person. (P9: Female, 38, RRMS, 8yrs) 
Some participants also described how timing affects receptiveness to prognosis information. Of 
those who mentioned timing, all felt the point of diagnosis was unsuitable (“If I’d have been 
given that info when I was diagnosed I would probably have jumped off a cliff.” P12: Female, 44, 
PP, 2yrs)).  Beyond that, there was no consensus between participants (or indeed certainty within 
individuals) about what constituted appropriate timing. 
 
There are times when you are ready to hear it and there are times when you are not […] you 
should be able to read people to know whether they want to know or whether they don’t because 
sometimes you can say ‘yes ok I’ll listen to it’ and then other times you think ‘oh I don’t want to 
hear this. (P4: Female, 56, SPMS, 22yrs) 
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Those that expressed an opinion about the mode of personalised prognosis information delivery 
favoured face-to-face communication from a HCP and were concerned with privacy and comfort 
of the setting. 
 
From a professional. A consultant. (P5: Female, 68, SPMS, 13yrs) 
Not a letter, not an email. (P1: Female, 45, RRMS, 16yrs) 
Relevant expertise was considered vital for prognosis information deliverers but support-giving 
skills were also considered pertinent and MS nurses were noted for having these.  
 
If I was going to be told about how in the future it will be really bad, I’d want someone who’s an 
expert who could answer any questions I had. Well I mean, I think that’s all. I wouldn’t mind 
what status they had but I’d just want them to be knowledgeable. (P3: Female, 65, SPMS, 9yrs) 
An MS nurse, because they are very well trained and very empathetic with the situation, to have 
an in-depth consultation with the person, in a neutral environment, to try and sort of lighten the 
picture rather than darken it. (P6: Male, 62, PPMS, 21yrs) 
Participants emphasised how they felt prognosis information should be communicated not as a 
one-off conversation but as part of joined-up care that prioritised their emotional wellbeing 
together with appropriate disease-modifying treatments and symptom management.  
 
They should have people that, other people around and place to support you after you have been 
told these things. (P2: Male, 48, PPMS, 20yrs) 
 
Discussion 
 
Key findings 
 
This study represents the first investigation into the experiences of pwMS regarding prognostic 
uncertainty and prognosis communication.  The analysis suggested that limited communication 
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about prognosis takes place between pwMS and HCPs, a finding which, together with the global 
dissatisfaction expressed about interactions with HCPs, was not unexpected and concurs with 
previous research on communication in MS (8, 21, 22). Interestingly though, participants 
apparently accepted prognostic uncertainty, and were highly ambivalent about the prospect of 
finding out more. The hesitancy about prognosis information contrasts with previous research 
characterising MS knowledge as empowering (22, 23) but concurs with research suggesting that 
pwMS work hard to evade the emotional threat of disease progression (18).   
 
In spite of minimal HCP communication and a realistic appreciation of the difficulties in accurate 
prognostication, we found that pwMS developed beliefs and expectations about their prognosis; 
particularly about the pace of worsening.  The idea of  personal beliefs about MS prognosis 
emerging over time is consistent with the Common-Sense Model of illness perception (24).  This 
theory’s central tenet is that patients develop ‘lay’ or ‘common-sense’ understandings of their 
health conditions based on abstract cultural knowledge about the illness (e.g. images of pwMS in 
wheelchairs), communication from authoritative sources such as HCPs (e.g. about variability) 
and personal symptom experiences. Common-sense understandings can be misaligned with 
medical opinion and are not necessarily declared by patients to HCPs. Importantly, research in 
MS and other diseases shows that regardless of their correspondence to reality, common-sense 
illness understandings influence coping, psychological and physical health outcomes (25-27) .   
 
Implications for clinical practice 
 
A number of novel findings emerged which should inform improvement of HCP behaviour 
around discussing and/or delivering prognostic estimates. Firstly, this study highlights the 
emotive nature of MS prognosis as a topic and indicates that pwMS may require careful 
preparation and emotional support when this is discussed; referral to psychology services or to 
patient support groups may be helpful for some patients, particularly given the fact that several 
participants referred to self-harm, suicide or having mental health difficulties as consequences of 
getting negative prognosis predictions It also appears that clinicians would benefit from training 
in skills for discussing prognosis and that the role of MS nurses, as well as neurologists, should 
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not be overlooked. Secondly, current findings demonstrated that although patients are unlikely to 
welcome detailed prognosis forecasts at diagnosis, early communication from neurologists, (even 
if brief and vague), about the variability of outcomes and the non-inevitability of wheelchair use 
is incredibly significant for pwMS, functioning to counter initial extreme and distressing illness 
perceptions. In early consultations clinicians could also acknowledge that prognosis-related 
discussions can be overwhelming whilst simultaneously conveying openness to revisiting 
dialogues when the pwMS feels ready.  
 
 
Finally, the ambivalence towards receiving forecasts of prognosis demonstrated in this study 
suggests that HCPs should not assume that all PwMS want to know their prognosis. It was clear 
that caution and sensitivity need to be exercised if prognosis forecasting tools are introduced into 
clinical practice and their predictions shared with pwMS.  Prognostic calculators appear to be 
best suited to presentation as part of a clinical consultation or support programme, rather than 
stand-alone tools.  
 
Limitations and future directions 
 
A number of limitations to the current study should be noted.  The first concerns sampling. We 
purposively sampled participants with varied clinical and sociodemographic characteristics in 
order to build up a picture of issues that are relevant for a range of pwMS.  However, in 
accordance with the qualitative methodology, we did not seek to sample representatively. The 
recruitment approach may have attracted those with strong views about prognosis communication 
and may have failed to recruit those less engaged with actively managing their MS, and those 
who use more denial and avoidance based coping strategies. If this was the case we might expect 
a representative sample to have less appetite for information about their prognosis. This study 
may also have attracted patients who have had negative experiences and/or limited 
communication with HCPs and who wanted to share their frustrations about this. If this was the 
case, our findings might indicate a more negative picture of patient-doctor communication than is 
warranted.  
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The suggestion that limited patient-HCP communication about personal prognosis takes place 
requires replication in a larger sample. It would also be valuable to establish whether the apparent 
paucity of prognosis communication is a UK phenomenon or more widespread; the limited 
existing research suggests scarcity might indeed be common (5, 6).   Research into HCPs’ views 
and experiences of prognostication in MS would also help to understand factors influencing 
prognosis communication.  
 
This study revealed substantial variability in responses to prognostic uncertainty and appetite for 
information. However, the study design was not suitable for detecting or quantifying associations 
between particular viewpoints or experiences and patient characteristics (e.g. progressive and 
relapsing remitting disease subtypes).   More research is needed to delineate which pwMS want 
more prognosis information and to establish the best timing and clinical setting to discuss 
prognosis. Large questionnaire studies would permit investigation of associations between 
prognosis information preferences and clinical, sociodemographic and psychological variables. 
 
This study collected only very limited clinical data (MS type and time since diagnosis) and this 
was by participant self-report. Although, anecdotally participants appeared to have no difficulties 
in remembering or communicating this information, it is possible that there may have been 
inaccuracies.  In the current study, objective clinical data on  use of disease modifying therapies, 
relapse severity/frequency,  neurological disability (EDSS) (28), date of conversion from RRMS 
to SPMS or speed of progression was not systematically collected. However, it did seem that 
pwMS’s own memories and impressions of the frequency and severity of disease activity strongly 
influenced their experience of their own disease to date, and that this fed into their expectations 
of the future. Exploration of the relationships between a wide range of clinical characteristics and 
the prognosis-related beliefs, expectations, experiences and preferences of pwMS could be a 
valuable direction for future research.  
  
Finally, this study did not explicitly raise the prospect of newly-emerging prognostication tools 
(e.g. OLAP(16)) with participants. Detailed studies of pwMS’s interest in and willingness to use 
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these tools and their impact on decision-making and psychological adjustment will be another 
important step towards understanding how beliefs and communication about prognosis affect the 
health and wellbeing of pwMS.   
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Supplementary Information A: Interview Schedule 
 
1. I want to ask you to think back to the time when you were first diagnosed with MS. 
What do you remember being told early on about how your MS might affect you over 
the longer term? 
a. Can you tell me about how you feel about  
i. What you were told 
ii. How you were told  
iii. Tell me about anything that could have gone better 
 
2. Can you remember any other/later occasions that your neurologist, MS nurse or GP 
talked to you about how your MS might affect you over the longer term 
a. Can you tell me how you feel about  
i. What you were told 
ii. How you were told  
iii. Tell me about anything that could have gone better 
 
3. How have your ideas about how MS is going to affect you changed or developed over 
the months or years since your diagnosis? 
 
4. Can I ask you about your current understanding of how your MS might affect you over the 
longer term? What are your beliefs or expectations about this? 
  a.      Who or what has influenced what you think or believe about this? 
  b.       Is there anything or anyone else that has been important in forming this view? 
 
5. How has your understanding about (or your uncertainty about) the likely long-term 
course of your MS affected you? 
a. Can you tell me about any ways that it has been helpful? 
b. Can you tell me about any ways that it has been unhelpful? 
 
6. Can you tell me about whether trying to get detailed or specific information about how 
your MS might progress is something important for you, personally, at the moment? 
a. Can you expand on what makes you feel like that? 
 
7. Who or what do you think could make things clearer for you? 
Any ideas of what sort of things would help you? 
 
8. In your opinion, what should health professionals think about when they talk to people 
with MS about how the disease might affect them in the future? 
 
Standard prompts for each question/sub question:   
• Can you tell me more about that?  
• Can you expand on that?  
• How did/do you feel?  
• What was/is that like for you? 
 
